Publications by authors named "Sureeporn Phlaetita"
Article Synopsis
- Head and neck squamous cell carcinoma (HNSCC) poses a challenge due to its complex nature and limited treatment options, leading to side effects and low survival rates with standard therapies.
- Research on halogenated benzoate derivatives of cleistanthin A revealed that ECDD-S18 was highly effective against HNSCC cells, outperforming the chemotherapy drug cisplatin while causing minimal harm to normal cells.
- ECDD-S18 promotes cancer cell death by disrupting lysosomal function and autophagy, along with downregulating mesenchymal markers and inhibiting cell migration, suggesting it holds potential as a therapeutic agent, especially in combination with drugs like cisplatin.
